
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

Pharmacy benefit managers under fire in House hearing
Pharmacy benefit managers, the middlemen who negotiate drug prices for millions of Americans, were grilled at a congressional hearing on July 23rd.
Watch the full congressional hearing here.

Ozempic shortages? Some pharmacists are choosing not to stock the drug at all
Some independent pharmacies are losing money on the pricey — and popular — drug.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.